Effects of a late add-on therapy of pegylated interferon (peg-IFNA) to ongoing nucleos(t)ide analogs (NUCs) in patients with chronic hepatitis B (CHB).
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Nucleosides; Nucleotides
- Indications Hepatitis B
- Focus Pharmacodynamics
- 01 Sep 2015 New trial record